Targeting sclerostin loop3 to promote bone formation with low cardiovascular risk in animal models

Medicine & Life Sciences

1. Osteogenesis 100%
2. Bone and Bones 87%
3. Cardiovascular Models 75%
4. romosozumab 60%
5. Osteoporosis 57%
6. Aortic Aneurysm 56%
7. Apolipoproteins E 51%
8. Cytokines 50%
9. Atherosclerosis 39%
10. Cardiovascular System 31%
11. Nucleotide Aptamers 23%
12. Drug Labeling 23%
13. Anabolic Agents 21%
14. Postmenopausal Osteoporosis 20%
15. Safety 18%
16. Antibodies 18%
17. Advisory Committees 17%
18. Angiotensin II 15%
19. Serum 14%
20. In Vitro Techniques 14%
21. Anti-Idiotypic Antibodies 13%
22. Interleukin-6 12%
23. Cardiovascular Diseases 11%
24. Animal Models 11%
25. Kidney 8%
26. Liver 8%
27. Therapeutics 7%